CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0705
-0.0246 (-25.87%)
At close: Oct 31, 2025
CERO Market Cap
CERO has a market cap or net worth of $131.49 thousand as of October 31, 2025. Its market cap has decreased by -99.03% in one year.
Market Cap
131.49K
Enterprise Value
6.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 131.49K, a decrease of -99.94%. That is a compound annual growth rate of -84.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 131.49K | -98.86% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 569.74M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 305.06M |
| CytoDyn | 302.34M |